For 30 years, Miltenyi Biotec has been dedicated to improving scientific understanding and medical progress for clinical research and cell and gene therapy (CGT). Our products and services facilitate the advancement of science in these key areas, and support clinicians who are bringing new cellular therapies to reality. We specialize in developing tailored cell processing protocols for the fully automated and closed, GMP-compliant CliniMACS Prodigy®. In addition, we offer comprehensive CGT support, including contract development and manufacturing of CGT products and tailored GMP lentiviral vectors.
Bio-Rad Laboratories, Inc. designs, manufactures, and distributes a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 7,750 employees and serves more than 100,000 research and industry customers worldwide through the company’s global network of operations.
Want to evaluate killing kinetics with physiologically relevant effector cell to target cell ratios? Concerned about the possible confounding effects of labeling your cells? Introducing Maestro Z from Axion BioSystems, the world’s most advanced impedance-based real-time cell analysis platform. Over minutes or weeks gain unprecedented access to the kinetics of your biology. Straightforward and easy to use, any researcher can now track immune cell-mediated killing in a 96-well plate.
As the possibilities of cellular therapy continue to expand by the day, you need a single solution that can manage all the changing requirements around data, reporting, and process. In addition, the growing use of CAR-T therapy means new data management challenges for both clinics and labs. WellSky Biotherapies software provides the solution with complete workflow management for both clinical and manufacturing programs. That means improved visibility into processes, on-demand analytics, and streamlined service coordination.
Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine and advance cell therapy companies, organizations and institutions. Cognate provides specialized custom services to companies across all points of clinical and commercial development ranging from early preclinical studies, to mid phase trials and product scale-up though later stage clinical trials and commercial manufacturing.